Mental Health ServicesNCT05952063
Validation of Schema Scale of Mental Health Service
An observational study of Mental Health Services and Personality, run by 40FY at 1 site in South Korea.
Trial summary
Digital Mental Health Service, MINDLiNG, has developed Schema Scale that identifies individual's personality based on schema theory. The goal of this study is to determine the reliability and validity of the Schema Scale. Read more about this study
- Who is it for?
- Ages 18 to 60 yearsHealthy volunteers can take part
- Conditions the study is for
- Mental Health Services, Personality
- What is being tested?
- Digital Psychological Test: Schema Scale
- How many people
- 234 participants
- Where
- 1 siteSouth Korea
- Study dates
- 26 Jul 2022to 16 Aug 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- All sexes
- Healthy volunteers accepted
- Adult
Study population: All adults who are willing to complete the online questionnaires.
Who may be able to join
- An adult who is able to independently read in Korean and fill out a survey form.
Who cannot join
- In cases where there is difficulty understanding and reading Korean.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Validation of the Korean Version of Schema Scale of Mental Health Service, MINDLiNG
Digital Mental Health Service, MINDLiNG, has developed Schema Scale that identifies individual's personality based on schema theory. The goal of this study is to determine the reliability and validity of the Schema Scale.
Read the detailed description
Most of the mental health service programs are limited to targeting specific psychiatric symptoms, which does not necessarily consider the personality and characteristics of individuals. To provide more personalized mental health care service, it is essential to identify the personality of individuals through valid psychological test.
Thus, MINDLiNG has developed the Schema Scale based on schema theory and psychodynamic theory in order to provide personalized and evidence-based treatment at the level of psychotherapy.
This study was conducted to evaluate the validity and reliability of the Schema Scale. The scale was administered online on non-clinical population (n = 234). The internal consistency of Schema Scale was evaluated. In addition, its factor structured was studied by exploratory and confirmatory factor analyses. Concurrent validity was examined by comparing the extracted Schema Scale factors with other psychological tests using Pearson's correlation tests.
- Conditions
- Mental Health Services, Personality
- Being tested
- Digital Psychological Test: Schema Scale
- Keywords
- maladaptive schema, mental health problem, personality test, digital mental health service
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Digital Psychological Test: Schema ScaleDiagnostic test
Thirty-five questionnaire, 5-point likert scale
What is being measured
The primary outcome is the main question the study is designed to answer.
Schema Scale
A 35-item questionnaire developed by 40FY for identifying 5-types of maladaptive schema types. The questionnaire consists of 5-point Likert scale. The Schema Scale was developed based on schema theory and other psychodynamic theories. The scale was developed by a certified psychiatrist and 3 clinical psychologists. A higher score for each factor means that the individual has more severe maladaptive psychological schemas.
Measured: Baseline
Perceived Stress Scale (PSS)
The PSS is a 10-item scale that measures the perceived stress on a 5-point severity with higher scores indicating more severe perceived stress.
Measured: Baseline
Self-Efficacy Stress (SES)
The SES is a 23-item scale that assesses the individuals self-efficacy on a 5-point likert scale. Higher scores indicate higher level of self-efficacy.
Measured: Baseline
Center for Epidemiologic Studies Depression Scale (CES-D)
The CES-D is a 20-item questionnaire that measures depressive symptoms on a 4-point likert scale.
Measured: Baseline
State-Trait Anxiety Inventory (STAI)
The STAI is a 40-item inventory that measures state and trait anxiety. Higher score means higher anxiety.
Measured: Baseline
UCLA Loneliness Scale (UCLA-LS)
A 20-item scale to measure subjective feelings of loneliness as well as feelings of social isolation on a 4-point likert scale.
Measured: Baseline
Short form of the Korean Inventory of Interpersonal Problems Circumplex Scale (KIIP-SC)
A 40-item scale to assess interpersonal problems on a 5-point likert scale.
Measured: Baseline
Diagnostic Test for Personality Disorders - Dependent subscale (DTPD-D)
A 15-item scale to assess dependent personality disorder traits on a 4-point likert scale.
Measured: Baseline
Strait-Trait Anger Expression Inventory (STAXI)
The STAXI is a psychometric assessment that measures state anger, trait anger, and anger expression by 44 items on a 4-point likert scale.
Measured: Baseline
UPPS-P Impulsive Behavior Scale
The scale is composed of 59 items on a 4-point likert scale assessing five factors of impulsivity including negative urgency, lack of premeditation, lack of perseverance, sensation seeking, and positive urgency.
Measured: Baseline
Hewitt Multidimensional Perfectionism Scale (HMPS)
The HMPS is a 45-item measure with three trait subscales measuring self-oriented perfectionism, other-oriented perfectionism, and socially prescribed perfectionism.
Measured: Baseline
State Self-Esteem Scale (SSES)
A 20-item scale on a 5-point likert scale assessing 3 facets of self-esteem: appearance, performance, and social.
Measured: Baseline
Rejection Sensitivity Questionnaire (RSQ)
The RSQ assesses anxious expectations regarding rejection with 18 hypothetical social situations on a 6-point likert scale.
Measured: Baseline
Beck Anxiety Inventory (BAI)
A 21-item self-inventory on a 4-point likert scale measuring common somatic and cognitive symptoms of anxiety.
Measured: Baseline
Intolerance of Uncertainty Scale-Short Form (IUS-12)
A 12-item questionnaire measures responses to uncertain and ambiguous situations that participants rate on a 5-point scale.
Measured: Baseline
Penn State Worry Questionnaire (PSWQ)
The PSWQ is a 16-item self-report questionnaire on a 5-point likert scale designed to measure the trait of worry in adults
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Jul 2023
- Study start26 Jul 2022
- Primary completion16 Aug 2022
- Study completion16 Aug 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Mental Health ServicesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
- Enrolment
- 234 participants (actual)
Sponsor and investigators
- Lead sponsor
- 40FY
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Seoul National University Hospital
- Responsible party
- Sponsor
- Investigators
- Min-Sup Shin, PhD, Principal investigator, Seoul National University College of Medicine, Department of Psychiatry
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05952063
- Sponsor's protocol ID
- SNUH_Schema_Scale
- Status last verified
- Jul 2023
- First submitted
- 11 Jul 2023
- Last updated
- 19 Jul 2023
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Kim H, Jeong S, Hwang I, Sung K, Moon W, Shin MS. Validation of a Brief Internet-Based Self-Report Measure of Maladaptive Personality and Interpersonal Schema: Confirmatory Factor Analysis. Interact J Med Res. 2023 Sep 29;12:e48425. doi: 10.2196/48425.
PubMed 37773606
Study at a glance
From the registry record, last updated by the sponsor on 19 Jul 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Validation of the Korean Version of Schema Scale of Mental Health Service, MINDLiNG
- ClinicalTrials.gov ID
- NCT05952063
- Acronym / sponsor ID
- SNUH_Schema_Scale
- Conditions
- Mental Health Services, Personality
- Keywords
- maladaptive schema, mental health problem, personality test, digital mental health service
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 234 participants (actual)
- Lead sponsor
- 40FYIndustry (pharma, biotech, devices)
- Collaborators
- Seoul National University Hospital
- Study start
- 26 Jul 2022 (actual)
- Primary completion
- 16 Aug 2022 (actual)
- Study completion
- 16 Aug 2022 (actual)
- First posted
- 19 Jul 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Digital Mental Health Service, MINDLiNG, has developed Schema Scale that identifies individual's personality based on schema theory. The goal of this study is to determine the reliability and validity of the Schema Scale.
Detailed description
Most of the mental health service programs are limited to targeting specific psychiatric symptoms, which does not necessarily consider the personality and characteristics of individuals. To provide more personalized mental health care service, it is essential to identify the personality of individuals through valid psychological test.
Thus, MINDLiNG has developed the Schema Scale based on schema theory and psychodynamic theory in order to provide personalized and evidence-based treatment at the level of psychotherapy.
This study was conducted to evaluate the validity and reliability of the Schema Scale. The scale was administered online on non-clinical population (n = 234). The internal consistency of Schema Scale was evaluated. In addition, its factor structured was studied by exploratory and confirmatory factor analyses. Concurrent validity was examined by comparing the extracted Schema Scale factors with other psychological tests using Pearson's correlation tests.
Study design
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 18 to 60 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- All adults who are willing to complete the online questionnaires.
Key inclusion criteria (1 listed)
- An adult who is able to independently read in Korean and fill out a survey form.
Key exclusion criteria (1 listed)
- In cases where there is difficulty understanding and reading Korean.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Digital Psychological Test: Schema ScaleThirty-five questionnaire, 5-point likert scale | Diagnostic test | – |
Primary outcome
Schema Scale
Time frame: Baseline
A 35-item questionnaire developed by 40FY for identifying 5-types of maladaptive schema types. The questionnaire consists of 5-point Likert scale. The Schema Scale was developed based on schema theory and other psychodynamic theories. The scale was developed by a certified psychiatrist and 3 clinical psychologists. A higher score for each factor means that the individual has more severe maladaptive psychological schemas.
Perceived Stress Scale (PSS)
Time frame: Baseline
The PSS is a 10-item scale that measures the perceived stress on a 5-point severity with higher scores indicating more severe perceived stress.
Self-Efficacy Stress (SES)
Time frame: Baseline
The SES is a 23-item scale that assesses the individuals self-efficacy on a 5-point likert scale. Higher scores indicate higher level of self-efficacy.
Center for Epidemiologic Studies Depression Scale (CES-D)
Time frame: Baseline
The CES-D is a 20-item questionnaire that measures depressive symptoms on a 4-point likert scale.
State-Trait Anxiety Inventory (STAI)
Time frame: Baseline
The STAI is a 40-item inventory that measures state and trait anxiety. Higher score means higher anxiety.
UCLA Loneliness Scale (UCLA-LS)
Time frame: Baseline
A 20-item scale to measure subjective feelings of loneliness as well as feelings of social isolation on a 4-point likert scale.
Short form of the Korean Inventory of Interpersonal Problems Circumplex Scale (KIIP-SC)
Time frame: Baseline
A 40-item scale to assess interpersonal problems on a 5-point likert scale.
Diagnostic Test for Personality Disorders - Dependent subscale (DTPD-D)
Time frame: Baseline
A 15-item scale to assess dependent personality disorder traits on a 4-point likert scale.
Strait-Trait Anger Expression Inventory (STAXI)
Time frame: Baseline
The STAXI is a psychometric assessment that measures state anger, trait anger, and anger expression by 44 items on a 4-point likert scale.
UPPS-P Impulsive Behavior Scale
Time frame: Baseline
The scale is composed of 59 items on a 4-point likert scale assessing five factors of impulsivity including negative urgency, lack of premeditation, lack of perseverance, sensation seeking, and positive urgency.
Hewitt Multidimensional Perfectionism Scale (HMPS)
Time frame: Baseline
The HMPS is a 45-item measure with three trait subscales measuring self-oriented perfectionism, other-oriented perfectionism, and socially prescribed perfectionism.
State Self-Esteem Scale (SSES)
Time frame: Baseline
A 20-item scale on a 5-point likert scale assessing 3 facets of self-esteem: appearance, performance, and social.
Rejection Sensitivity Questionnaire (RSQ)
Time frame: Baseline
The RSQ assesses anxious expectations regarding rejection with 18 hypothetical social situations on a 6-point likert scale.
Beck Anxiety Inventory (BAI)
Time frame: Baseline
A 21-item self-inventory on a 4-point likert scale measuring common somatic and cognitive symptoms of anxiety.
Intolerance of Uncertainty Scale-Short Form (IUS-12)
Time frame: Baseline
A 12-item questionnaire measures responses to uncertain and ambiguous situations that participants rate on a 5-point scale.
Penn State Worry Questionnaire (PSWQ)
Time frame: Baseline
The PSWQ is a 16-item self-report questionnaire on a 5-point likert scale designed to measure the trait of worry in adults
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Jul 2023.
- Derived from this study: PubMed 37773606Kim H, Jeong S, Hwang I, Sung K, Moon W, Shin MS. Validation of a Brief Internet-Based Self-Report Measure of Maladaptive Personality and Interpersonal Schema: Confirmatory Factor Analysis. Interact J Med Res. 2023 Sep 29;12:e48425. doi: 10.2196/48425.
- Individual participant dataSharing planned: No
Related trials for Mental Health Services
Active, not recruiting
MEST : A School- Based Health Literacy Intervention Trial
Health Literacy, Adolescent Health
Active, not recruiting
PREWELL Digital Well-being Promotion Intervention With the BitHabit App
General Mental Health and Well-Being, Mental Disorders
Not yet recruiting
QAIAx - SGI/SI Smart Health Cities: Microcity Enclave Program (Quantum SI/AGI Agency a/k/a AI City Hall Project - UPSTO App Nos. 64/074,526, 64/063,557, 64/105,164, 63/903,181, 63/729,428, 64/125,360; USPTO EO 9424 Assignment ID: 2101042 / ARN: REEL/FRAME: 76481/0026 - OUSD-R&E, Department of War)
Asperger's Disorder, Asperger Disorder
Not yet recruiting
Pilot Study to Co-create and Implement a Multicomponent Intervention to Reduce Mental Health Stigma in Primary Care
Mental Health, Stigma of Mental Illness
Active, not recruiting
Pai.ACT: AI-Driven ACT Chatbot for Mental Health Triage and Service Evaluation
Autism Spectrum Disorder, Attention Deficit Disorder With Hyperactivity (ADHD)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Min-Sup Shin, PhD principal investigator
Seoul National University College of Medicine, Department of Psychiatry
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Mental Health Services and Personality, run by 40FY at 1 site in South Korea.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Schema Scale (time frame: Baseline). The study lists 16 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05952063, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Jul 2023.